中华妇产科杂志
中華婦產科雜誌
중화부산과잡지
CHINESE JOUNAL OF OBSTETRICS AND GYNECOLOGY
2013年
10期
740-744
,共5页
曹远奎%张绍芬%邹世恩%夏贤%许琳娜
曹遠奎%張紹芬%鄒世恩%夏賢%許琳娜
조원규%장소분%추세은%하현%허림나
绝经期%雄激素类%胰岛素抵抗
絕經期%雄激素類%胰島素牴抗
절경기%웅격소류%이도소저항
Menopause%Androgens%Insulin resistance
目的 探讨绝经后早期、晚期内源性雄激素水平及活性变化与胰岛素抵抗之间的相关性.方法 募集2009年9月至2011年9月在复旦大学附属妇产科医院就诊的绝经后早期妇女(绝经时间≤5年)105例(绝经后早期组)、绝经后晚期妇女(绝经时间≥10年)107例(绝经后晚期组),并进一步根据体质指数(BMI)分为正常体质量者(BMI< 24 kg/m2)和超重者(BMI≥24 kg/m2).采用全自动生化分析仪测定空腹血糖(FBG)水平;采用全自动化学发光仪测定睾酮、硫酸脱氢表雄酮(DHEA-S)、性激素结合球蛋白(SHBG)及空腹胰岛素(FINS)水平,并计算游离雄激素指数(FAI,代表雄激素活性)和稳态模型胰岛素抵抗指数(HOMA-IR);采用偏相关分析法、多元线性回归法分析SHBG、FAI、睾酮、DHEA-S与胰岛素抵抗的相关性.结果 绝经后晚期组妇女FINS[(7.9±6.6) mU/L]、HOMA-IR(2.1±1.9)高于绝经后早期组[FINS水平为(6.6 ±4.0) mU/L、HOMA-IR为1.7±1.1],而绝经后晚期组DHEA-S为(0.9±0.5)mg/L,低于绝经后早期组的(1.1 ±0.5) mg/L,两组上述各指标间分别比较,差异均有统计学意义(P<0.05).两组妇女中,超重者HOMA-IR(绝经后早期组为2.2±1.0;绝经后晚期组为2.8±2.6)、FINS[绝经后早期组(6.9±2.9)mU/L;绝经后晚期组(10.2 ±9.3)mU/L]高于正常体质量者HOMA-IR(绝经后早期组为1.2±0.9;绝经后晚期组为1.6±1.1)、FINS[绝经后早期组(4.6±2.0)mU/L;绝经后晚期组(6.4±3.6)mU/L],差异有统计学意义(P<0.05).绝经后早期组妇女中,超重者SHBG[(52±37) nmol/L]低于正常体质量者[(71±37) nmol/L],而超重者FAI(2.5 ±2.1)高于正常体质量者(1.3±1.1);在绝经后晚期组妇女中,超重者DHEA-S为(1.0±0.5)mg/L,高于正常体质量者的(0.8±0.4)mg/L,分别比较差异均有统计学意义(P<0.05).绝经后早期组妇女SHBG与FINS、HOMA-IR呈负相关(β值分别为-0.386、-0.553,P均<0.05),DHEA-S与FBG呈正相关(β=0.348,P<0.05);绝经后晚期妇女FAI与FBG呈正相关(β=0.505,P<0.05).结论 绝经后雄激素活性相对升高与胰岛素抵抗风险增加有关,这种相关性在绝经后不同阶段表现有所不同,主要表现为在绝经后早期SHBG与胰岛素抵抗风险增加呈负相关,DHEA-S与血糖升高风险呈正相关;在绝经后晚期,FAI与血糖升高风险呈正相关.
目的 探討絕經後早期、晚期內源性雄激素水平及活性變化與胰島素牴抗之間的相關性.方法 募集2009年9月至2011年9月在複旦大學附屬婦產科醫院就診的絕經後早期婦女(絕經時間≤5年)105例(絕經後早期組)、絕經後晚期婦女(絕經時間≥10年)107例(絕經後晚期組),併進一步根據體質指數(BMI)分為正常體質量者(BMI< 24 kg/m2)和超重者(BMI≥24 kg/m2).採用全自動生化分析儀測定空腹血糖(FBG)水平;採用全自動化學髮光儀測定睪酮、硫痠脫氫錶雄酮(DHEA-S)、性激素結閤毬蛋白(SHBG)及空腹胰島素(FINS)水平,併計算遊離雄激素指數(FAI,代錶雄激素活性)和穩態模型胰島素牴抗指數(HOMA-IR);採用偏相關分析法、多元線性迴歸法分析SHBG、FAI、睪酮、DHEA-S與胰島素牴抗的相關性.結果 絕經後晚期組婦女FINS[(7.9±6.6) mU/L]、HOMA-IR(2.1±1.9)高于絕經後早期組[FINS水平為(6.6 ±4.0) mU/L、HOMA-IR為1.7±1.1],而絕經後晚期組DHEA-S為(0.9±0.5)mg/L,低于絕經後早期組的(1.1 ±0.5) mg/L,兩組上述各指標間分彆比較,差異均有統計學意義(P<0.05).兩組婦女中,超重者HOMA-IR(絕經後早期組為2.2±1.0;絕經後晚期組為2.8±2.6)、FINS[絕經後早期組(6.9±2.9)mU/L;絕經後晚期組(10.2 ±9.3)mU/L]高于正常體質量者HOMA-IR(絕經後早期組為1.2±0.9;絕經後晚期組為1.6±1.1)、FINS[絕經後早期組(4.6±2.0)mU/L;絕經後晚期組(6.4±3.6)mU/L],差異有統計學意義(P<0.05).絕經後早期組婦女中,超重者SHBG[(52±37) nmol/L]低于正常體質量者[(71±37) nmol/L],而超重者FAI(2.5 ±2.1)高于正常體質量者(1.3±1.1);在絕經後晚期組婦女中,超重者DHEA-S為(1.0±0.5)mg/L,高于正常體質量者的(0.8±0.4)mg/L,分彆比較差異均有統計學意義(P<0.05).絕經後早期組婦女SHBG與FINS、HOMA-IR呈負相關(β值分彆為-0.386、-0.553,P均<0.05),DHEA-S與FBG呈正相關(β=0.348,P<0.05);絕經後晚期婦女FAI與FBG呈正相關(β=0.505,P<0.05).結論 絕經後雄激素活性相對升高與胰島素牴抗風險增加有關,這種相關性在絕經後不同階段錶現有所不同,主要錶現為在絕經後早期SHBG與胰島素牴抗風險增加呈負相關,DHEA-S與血糖升高風險呈正相關;在絕經後晚期,FAI與血糖升高風險呈正相關.
목적 탐토절경후조기、만기내원성웅격소수평급활성변화여이도소저항지간적상관성.방법 모집2009년9월지2011년9월재복단대학부속부산과의원취진적절경후조기부녀(절경시간≤5년)105례(절경후조기조)、절경후만기부녀(절경시간≥10년)107례(절경후만기조),병진일보근거체질지수(BMI)분위정상체질량자(BMI< 24 kg/m2)화초중자(BMI≥24 kg/m2).채용전자동생화분석의측정공복혈당(FBG)수평;채용전자동화학발광의측정고동、류산탈경표웅동(DHEA-S)、성격소결합구단백(SHBG)급공복이도소(FINS)수평,병계산유리웅격소지수(FAI,대표웅격소활성)화은태모형이도소저항지수(HOMA-IR);채용편상관분석법、다원선성회귀법분석SHBG、FAI、고동、DHEA-S여이도소저항적상관성.결과 절경후만기조부녀FINS[(7.9±6.6) mU/L]、HOMA-IR(2.1±1.9)고우절경후조기조[FINS수평위(6.6 ±4.0) mU/L、HOMA-IR위1.7±1.1],이절경후만기조DHEA-S위(0.9±0.5)mg/L,저우절경후조기조적(1.1 ±0.5) mg/L,량조상술각지표간분별비교,차이균유통계학의의(P<0.05).량조부녀중,초중자HOMA-IR(절경후조기조위2.2±1.0;절경후만기조위2.8±2.6)、FINS[절경후조기조(6.9±2.9)mU/L;절경후만기조(10.2 ±9.3)mU/L]고우정상체질량자HOMA-IR(절경후조기조위1.2±0.9;절경후만기조위1.6±1.1)、FINS[절경후조기조(4.6±2.0)mU/L;절경후만기조(6.4±3.6)mU/L],차이유통계학의의(P<0.05).절경후조기조부녀중,초중자SHBG[(52±37) nmol/L]저우정상체질량자[(71±37) nmol/L],이초중자FAI(2.5 ±2.1)고우정상체질량자(1.3±1.1);재절경후만기조부녀중,초중자DHEA-S위(1.0±0.5)mg/L,고우정상체질량자적(0.8±0.4)mg/L,분별비교차이균유통계학의의(P<0.05).절경후조기조부녀SHBG여FINS、HOMA-IR정부상관(β치분별위-0.386、-0.553,P균<0.05),DHEA-S여FBG정정상관(β=0.348,P<0.05);절경후만기부녀FAI여FBG정정상관(β=0.505,P<0.05).결론 절경후웅격소활성상대승고여이도소저항풍험증가유관,저충상관성재절경후불동계단표현유소불동,주요표현위재절경후조기SHBG여이도소저항풍험증가정부상관,DHEA-S여혈당승고풍험정정상관;재절경후만기,FAI여혈당승고풍험정정상관.
Objective To investigate the relationship between insulin resistance and endogenous androgens at early and late phase of postmenopause.Methods A total of 105 women with early postmenopause (≤5 years since menopause) and 107 women with late postmenopause (≥ 10 years since menopause) were enrolled in this study.In the mean time,those women were classified into normal weight [body mass index (BMI),BMI <24 kg/m2] group and overweight (BMI≥24 kg/m2) group.Sex hormonebinding globulin (SHBG),testosterone (T),dehydroepiandrosterone-sulfate (DHEA-S),fasting blood glucose(FBG),fasting insulin (FINS)levels were measured and then calculated free androgen index(FAI) and homeostatic model assessment of insulin resistance (HOMA-IR).The relationship between sex hormones and insulin resistance was analyzed by partial correlation and multiple linear regression analyses.Results Compared to early postmenopausal women,late postmenopausal women had higher FINS [(7.9 ± 6.6) mU/L versus (6.6 ±4.0) mU/L] and HOMA-IR(2.1 ± 1.9 versus 1.7 ± 1.1),but they had lower DHEA-S [(0.9 ± 0.5) mg/L versus (1.1 ± 0.5) mg/L,all P < 0.05)].Both in early postmenopausal and late postmenopausal groups,overweight women had higher HOMA-IR (early group,2.2 ± 1.0 versus 1.2 ±0.9 ; late group,2.8 ± 2.6 versus 1.6±1.1)and FINS early group[(6.9±2.9) mU/L versus (4.6±2.0) mU/L] ;late group [(10.2 ± 9.3) mU/L versus (6.4 ± 3.6) mU/L] than those at women with normal weight group(all P < 0.05).In early postmenopausal group,overweight women had lower SHBG [(52 ±37) nmol/L versus (71 ±37) nmol/L] and higher FAI(2.5 ±2.1) versus (1.3 ± 1.1) than those at normal weight women group(all P < 0.05).In late postmenopausal group,overweight women had higher DHEA-S (1.0 ± 0.5) mg/L versus (0.8 ± 0.4) mg/L (P < 0.05).The analyses suggested that in early postmenopausal group,SHBG was correlated negatively with FINS and HOMA-IR (β =-0.386,P < 0.05 ;β =-0.553,P <0.05),DHEA-S was correlated positively with FBG (β =0.348,P < 0.05) in early postmenopausal group.FAI was correlated positively with FBG in late postmenopausal group (β =0.505,P < 0.05).Conclusions The increased androgenic activities are associated with insulin resistance after of menopause.These correlations are different at different stages of postmenopause,which SHBG levels correlate with high risk of insulin resistance and DHEA-S levels correlates with high blood glucose levels at early postmenopause and FAI correlates with high blood glucose levels at late postmenopause.